Global Rheumatoid Arthritis Market 2018 Key Players: Merck, Janssen Biologics B.V., Pfizer Limited, Amgen, Novartis, GSK.

Rheumatoid Arthritis Market:

Executive Summary

Adroit Healthcare Services Rheumatoid Arthritis - Competitive Landscape and Market, Market Access Potential, Pricing & Pipeline Analysis, 2018' provide the comprehensive research on the competitive landscape and therapies indicated for rheumatoid arthritis.

The report is built with the in-depth secondary research, understanding the market access aspects across the different countries. The main objective of this report is to provide a comprehensive secondary research and market analysis of different therapies indicated for rheumatoid arthritis including the market access and reimbursement challenges across EU5 and US.

The report includes in depth sales reports of different class of therapies, detailed mechanism of action, comprehensive clinical trial data, time line of important events, pricing and market access across the significant markets (EU3+US). This report also includes the pipeline analysis of filed, phase 3, phase 2, phase 1, preclinical products across the different classes.

This report also provides comprehensive research on the companies that are working on different class of drugs for rheumatoid arthritis including the deals and acquisitions (collaborations and merges).

Companies Mentioned

Merck, Janssen Biologics B.V., Pfizer Limited, Amgen, Novartis, GSK, Celgene, Eli Lilly, Abbvie, Sanofi

Request Sample Report @ https://www.wiseguyreports.com/sample-request/3096398-rheumatoid-arthritis-competitive-landscape-and-market-market-access

Table of Content

Disease Landscape

• Etiology and Pathophysiology
• Disease Overview
• Key Pathways and Drug Targets

Market Overview

Therapeutic assessment by drug class

• TNF-Alpha Inhibitors
• B-Cell-Targeted Therapies
• IL-6 Inhibitors
• JAK Inhibitors
• RANKL Inhibitors
• Adenosine Receptor Agonists

Market Drivers and Constraints

Current Treatment Overview

Key Findings

Key Current Therapies

• Humira & Biosimilars
• Remicade & Biosimilars
• Enbrel & Biosimilars
• Simponi
• Cimzia
• Orencia
• Olumiant
• Rituxan/MabThera
• Kineret
• Kevzara

Biosimilars Drug profiling

• GP2017/Sandoz
• BI695501/Boehringer Ingelheim
• PF-06410293/Pfizer
• FKB327/Fujifilm Kyowa Kirin Biologics
• MYL-1401A/Biocon/Mylan
• CHS-1420/Coherus
• M923/Momenta
• ONS-3010/Oncobiologics/ Viropro
• MSB11022/Fresenius

Unmet Need Overview

Pipeline Analysis

• Late Stage Pipeline Analysis
• Mid Stage Pipeline Analysis
• Early Stage Pipeline Analysis
• Discontinued Products

Access & Reimbursement Overview

• United States
• EU5

Continuous…

For further information on this report, visit – https://www.wiseguyreports.com/reports/3096398-rheumatoid-arthritis-competitive-landscape-and-market-market-access

Contact Us:

Norah Trent           

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US); +44 208 133 9349 (UK)